The new Covid-19 vaccines’ success hinges on getting people to come back for a second shot after the first dose. That’s been a challenge in the past, and scientists fear skipped inoculations will drag out the pandemic.
Historically, a significant portion of people fail to follow through on vaccine schedules that require multiple doses; sometimes fewer than half of participants returned for the second shot. The leading Covid-19 vaccine candidates from Pfizer and Moderna both require two shots. If enough people skip the second injection, that risks prolonging the pandemic.
Scientists aren’t sure how effective only one dose of ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.